Related Experiment Video

Updated: Apr 4, 2026

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
11:35

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells

Published on: June 16, 2017

13.4K

CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X

Madina Karimova1, Niklas Beschorner1, Werner Dammermann2

  • 1Heinrich Pette Institute - Leibniz Institute for Experimental Virology, 20251 Hamburg, Germany.

Scientific Reports
|September 4, 2015
PubMed

Insights

Researchers explored CRISPR/Cas9 nickase technology to target and inactivate the hepatitis B virus (HBV) genome. This novel approach shows promise for developing a functional cure for chronic HBV infection by disrupting viral DNA.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Editing Technologies

Background:

  • Current antiviral therapies for hepatitis B virus (HBV) infection are insufficient for complete eradication.
  • The persistent HBV genome exists mainly as episomal covalently closed circular DNA (cccDNA) and integrated sequences within host cells.
  • CRISPR/Cas9 RNA-guided nucleases offer a potential strategy to directly target and inactivate the HBV genome.

Purpose of the Study:

  • To investigate the therapeutic potential of CRISPR/Cas9 nickase system for HBV genome inactivation.
  • To identify cross-genotype conserved HBV sequences for targeted genome editing.
  • To assess the efficacy of Cas9 nickase in disrupting HBV cccDNA and integrated sequences and inhibiting viral replication.

Main Methods:

  • Identification of conserved HBV sequences in the S and X regions across different genotypes.
  • Design and application of a Cas9 nickase system to target these conserved sequences.
  • Evaluation of HBV genome disruption in reporter cell lines and inhibition of viral replication in infected hepatoma cell lines.

Main Results:

  • Successfully identified cross-genotype conserved HBV sequences in the S and X regions.
  • Demonstrated specific and effective cleavage of episomal cccDNA and integrated HBV DNA by the Cas9 nickase.
  • Showed significant disruption of HBV replication in both chronically and de novo infected hepatoma cell lines.

Conclusions:

  • The CRISPR/Cas9 nickase system effectively targets and disrupts the HBV genome, including persistent cccDNA.
  • This gene-editing approach demonstrates feasibility for developing novel therapeutic strategies aimed at curing HBV infection.
  • The findings support the potential of CRISPR/Cas9 technology for achieving a functional cure for hepatitis B.

More Related Videos

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing12:21

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Published on: January 7, 2019

14.4K
Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

7.3K

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.7K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
59.3K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.6K
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
999
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.7K
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
42